Form 4: McKesson Corp Director Julie L. Gerberding Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Julie L. Gerberding, a director of McKesson Corp, reports acquiring 176 Restricted Stock Units (RSUs) on February 7, 2025, which vest immediately but are deferred until she leaves the board.

Summary

  • On February 7, 2025, Julie L. Gerberding, a director of McKesson Corp, acquired 176 Restricted Stock Units (RSUs).
  • The RSUs were granted upon her election to the Board under the 2022 Stock Plan.
  • The grant vests immediately, but the receipt of the underlying stock is deferred until she leaves the Board.
  • Following the transaction, Gerberding directly owns 176 shares of Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard equity grant to a director, indicating alignment of interests and confidence in the company's future.

Positives

  • The grant of RSUs to a director aligns her interests with the long-term performance of the company.
  • Immediate vesting of the RSUs indicates confidence in the director's continued service.

Future Outlook

The reporting person will receive shares of McKesson Corp common stock when they leave the board.

Industry Context

This filing is a routine disclosure of equity compensation to a board member, common in publicly traded companies to align director interests with shareholder value.

Comparison to Industry Standards

  • Equity compensation for board members is a standard practice across publicly traded companies, including McKesson's peers in the healthcare distribution industry such as Cardinal Health (CAH) and AmerisourceBergen (ABC).
  • The vesting and deferral terms are typical, often designed to incentivize long-term commitment and align with shareholder interests.
  • Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also utilize similar equity-based compensation plans for their directors.

Stakeholder Impact

  • Shareholders: The grant aligns the director's interests with shareholder value.
  • Employees: The grant is unlikely to have a direct impact on employees.
  • Customers and Suppliers: The grant is unlikely to have a direct impact on customers or suppliers.

Key Dates

DateDescription
02/07/2025Date of the transaction where Julie L. Gerberding acquired 176 Restricted Stock Units (RSUs).
02/10/2025Date of signature for the report by Sarah Ahmad Ali, Attorney-in-fact.

Keywords

Form 4, McKesson Corp, Director, Restricted Stock Units, RSUs, Beneficial Ownership, Gerberding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.